Table 3 Patient characteristics between non-dilated and dilated left ventricle

Age (years)

69.98 ± 8.16

68.35 ± 6.95

NS

Male (n, %)

31 (75.6)

16 (94.1)

NS

Body mass index (kg/m²)

30.05 ± 3.85

28.85 ± 2.71

NS

Body surface area (m²)

2.04 ± 0.17

2.04 ± 0.21

NS

Waist circumference (cm)

104.59 ± 9.65

103.65 ± 7.40

NS

History of hypertension (n, %)

38 (92.7)

15 (88.2)

NS

Mean arterial pressure (mmHg)

100.34 ± 13.96

96.90 ± 11.37

NS

Dyslipidemia (n, %)

28 (68.3)

13 (76.5)

NS

Smoking (n, %)

21 (51.2)

14 (82.4)

0.027

Family History (n, %)

18 (43.9)

6 (35.3)

NS

Duration Diabetes (years)

10.11 ± 8.29

11.32 ± 9.31

NS

Diabetic Polyneuropathy (n, %)

7 (17.1)

6 (35.3)

NS

Diabetic Retinopathy (n, %)

5 (12.2)

3 (17.6)

NS

Previous PCI (n, %)

13 (31.7)

8 (47.1)

NS

Previous MI (n, %)

6 (14.6)

8 (47.1)

0.009

Laboratory parameters

- Hb_A1C (mmol/mol)

53.02 ± 8.49

51.27 ± 14.34

NS

- Fasting glucose (mg/dl)

163.41 ± 57.42

158.88 ± 44.30

NS

- Total cholesterol (mg/dl)

190.83 ± 43.81

193.59 ± 51.29

NS

- LDL-cholesterol (mg/dl)

114.78 ± 32.23

123.06 ± 45.67

NS

- HDL-cholesterol (mg/dl)

45.20 ± 10.79

40.35 ± 5.57

0.029

- Triglycerides (mg/dl)

183.49 ± 96.28

170.12 ± 76.70

NS

- GFR (ml/min/1.73 m²)

76.22 ± 23.64

72.93 ± 22.89

NS

Medical therapy prior to coronary angiography n (%)

- Metformin (n, %)

30 (73.2)

11 (64.7)

NS

- Insulin (n, %)

14 (34.1)

7 (41.2)

NS

- Sulfonylurea (n, %)

11 (26.8)

2 (11.8)

NS

- Incretin-based therapy (n, %)

11 (26.8)

2 (11.8)

NS

- Statin (n, %)

27 (65.9)

14 (82.4)

NS

- ACE-Inh./ARB (n, %)

32 (78.0)

11 (64.7)

NS

- ß-Blocker (n, %)

31 (75.6)

14 (82.4)

NS

- ASA (n, %)

38 (92.7)

16 (94.1)

NS